← Leaderboards
C Ross Ethier
Georgia Institute Of Technology
$6,142,317
Attributed
$11,697,504
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,697,504 · 8
By mechanism
R01$10,860,447 · 5
R21$827,057 · 2
R13$10,000 · 1
Top collaborators
- W Daniel Stamer8 shared
- Stanislav Y Emelianov7 shared
- Markus H. Kuehn7 shared
- Felipe Medeiros5 shared
- Maureen A Kane4 shared
- Machelle T. Pardue4 shared
- Sina Farsiu2 shared
- Divakar Gupta1 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Andres J Garcia$26,499,681
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaTissuesRisk FactorsOcular HypertensionBlindnessPhysiologic Intraocular PressureInnovationIn VivoGlossaryAbbreviationsImagePropertyTrabecular Meshwork StructureExperimental StudyPressurePrimary Open Angle GlaucomaPathway InteractionsTechnologyResponsePhysiologicalPhysiologyDesignCellsFunctional Disorder
Grant awards (29)
Quantitative assessment of glaucomatous conventional outflow dynamics$589,950
R01 · FY2025 · EY
Mechanisms of axial elongation in myopia$559,114
R01 · FY2025 · EY
Quantitative assessment of glaucomatous conventional outflow dynamics$719,160
R01 · FY2024 · EY
Mechanisms of axial elongation in myopia$562,204
R01 · FY2024 · EY
Mechanisms of axial elongation in myopia$590,454
R01 · FY2023 · EY
OCT Measurement of Trabecular Meshwork Function In Vivo$536,516
R01 · FY2023 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$621,369
R01 · FY2022 · EY · contact PI
Mechanisms of axial elongation in myopia$598,845
R01 · FY2022 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$498,222
R01 · FY2022 · EY · contact PI
Schlemmâs canal on a chip: A platform for screening a novel class of glaucoma medications$211,912
R21 · FY2022 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$77,785
R01 · FY2022 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$598,021
R01 · FY2021 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$498,394
R01 · FY2021 · EY · contact PI
Schlemmâs canal on a chip: A platform for screening a novel class of glaucoma medications$193,467
R21 · FY2021 · EY · contact PI
Transcriptional and Biomechanical Analysis of Segmental Outflow in Glaucoma$78,724
R01 · FY2021 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$76,362
R01 · FY2021 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$75,451
R01 · FY2021 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$531,506
R01 · FY2020 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$493,667
R01 · FY2020 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$77,785
R01 · FY2020 · EY · contact PI
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma$549,251
R01 · FY2019 · EY · contact PI
Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma$495,843
R01 · FY2019 · EY · contact PI
Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma$508,027
R01 · FY2018 · EY · contact PI
Genomic Loci Modulating Biomechanics and Glaucoma in Recombinant Inbred Mice$183,536
R21 · FY2018 · EY · contact PI
Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma$504,151
R01 · FY2017 · EY · contact PI
Genomic Loci Modulating Biomechanics and Glaucoma in Recombinant Inbred Mice$238,142
R21 · FY2017 · EY · contact PI
Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma$504,829
R01 · FY2016 · EY · contact PI
Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma$514,817
R01 · FY2015 · EY · contact PI
Summer Biomechanics, Biotransport and Bioengineering Conference 2014 (SB3C2105)$10,000
R13 · FY2015 · EB · contact PI